Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B vaccination in post-liver transplant patients
ChiCTR2600124168Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- May 2026
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of hepatitis b vaccine recombinant in hepatitis B (HBV), Cirrhosis, hepatocellular carcinoma (HCC) and 1 more (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: Hepatitis B surface antibody. Started May 2026; status: recruiting.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)Cirrhosishepatocellular carcinoma (HCC)hepatic failure
Beyond the preview
Go deeper on ChiCTR2600124168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124168.